Delivery Order SPE2DB22D1106-SPE2DB25FEQM1

Award Date 5/28/25
Potential Completion Date 5/29/25
Potential Value $9.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $34,618.76, is for the delivery of emtricitabine-tenofovir 200-300 mg pharmaceutical products. It is a firm fixed-price contract with a period of performance through March 3, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Emtricitabine-Tenofv 200-300mg medication, a type of prescription drug. The contract has a ceiling value of $2,105.92 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,904.67 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of emtricitabine-tenofovir 200-300 mg pharmaceutical products. This delivery order contract is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for $9,625.87 for the supply of Emtricitabine-Tenofovir 200-300mg tablets. The contract has a firm fixed price and an ultimate completion date of November 16, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range...
This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $29,949.47, is a delivery order for Emtricitabine-Tenofovir 200-300 mg medication in 30-count bottles. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2025. The contract is not set aside and is an open competition award. AmerisourceBergen Drug Corp...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,752.24 firm fixed-price contract is for the supply of emtricitabine-tenofv 200-300mg tablets for a term ending on November 19, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,116.81 firm fixed-price delivery order contract is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The award has an ultimate completion date of August 28, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,856.62 Delivery Order award is for the provision of Emtricitabine-Tenofovir 200-300 mg prescription medication. The contract has a completion date of June 30, 2023 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $4,177.73 firm fixed-price delivery order is for the supply of 4568123008 units of the pharmaceutical product Emtricitabine-Tenofovir 200-300mg. The contract has a performance period through May 5, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $47,350.48, is for the delivery of emtricitabine-tenofovir 200-300 mg tablets. The contract is a Firm Fixed Price Delivery Order with a completion date of November 30, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEQM1
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug emtricitabine-tenofovir 200-300 mg. The contract is a firm-fixed-price delivery order with a ceiling value of $9,138.74 and a period of performance through May 29, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order is not designated as a set-aside contract, indicating open competition. The award enables AmerisourceBergen to supply this critical medication to support military healthcare programs and other government agency requirements.

Generated 8/27/25, 9:49 AM